. Nixon said state and federal court systems, not European politicians, will decide death penalty policy in Missouri. “A number of courts have already had an opportunity to review this matter,” Nixon said, referring to broader legal challenges to the death penalty. “We’re going to continue to monitor it very closely. At this point, there’s no stay in effect.” On Friday, the American Civil Liberties Union filed a lawsuit against the Missouri Department of Corrections, alleging that the agency failed to comply with open records requests related to its planned use of propofol in executions. The Missouri Society of Anesthesiologists has also urged the state to reconsider using propofol, warning that Missouri “is on the verge of triggering a national drug shortage that will have a severe impact on the general welfare of the citizens of our state and our country.” The U.S. Food and Drug Administration has also expressed concern about any move that would limit access to the drug. Missouri turned to propofol for executions only after the drugs it and other states previously used for lethal injection could no longer be obtained by prisons and corrections departments because drug makers did not approve of such uses. Propofol is America’s most popular anesthetic, according to the American Society of Anesthesiologists. About 50 million vials are administered annually in some 15,000 U.S. hospitals and clinics about four-fifths of all anesthetic procedures. The society said in a statement that propofol is popular because it works quickly and patients wake up faster with fewer side effects such as post-operative nausea. Convicted killer Allen Nicklasson is scheduled to die by injection on Oct.
official has warned that exempting industries will be “death by a thousand cuts” for the talks. Europe’s exemptions could embolden Washington to pursue opt-outs for its shipping industry on security grounds, or restrict access to the vast U.S. government procurement industry. Financial ties between Europe and the United States are already huge, accounting for 60 percent of world banking. EU investors own $2.7 trillion of U.S. stocks and bonds, while U.S. residents hold almost as much in Europe. However, the United States and European countries regulate banks, insurers and traders in very different ways, particularly in the $630 trillion derivatives industry. COLD SHOULDER Never was the difference more evident than during the financial crisis, when Washington moved quickly in 2008 to tackle problems at its banks with a compulsory scheme to take on new capital, reassuring investors. Five years on, Europe and its uneasy alliance of 28 countries is still struggling to impose order on its financial system and has had to give emergency aid to five countries. This is mirrored in regulation, where the two sides have also clashed over the control of derivatives, with Washington demanding that global trading involving U.S. firms be subject only to U.S. rules, regardless of where it happens. Europe wants a pact that spells out which regulators are responsible for what activities, and how the rules should apply. Some EU officials talk about creating new EU-U.S.